Advertisement
Pharmaceuticals and Biotech
Subscribe to Pharmaceuticals and Biotech

The Lead

Novartis, Glaxo, Lilly In Multibillion-Dollar Deals

April 22, 2014 12:22 pm | by John Heilprin, Associated Press | News | Comments

Swiss pharmaceutical giant Novartis announced a series of multibillion-dollar deals with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.       

Valeant, Ackman Make $45B Bid For Allergan

April 22, 2014 8:47 am | News | Comments

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer...

ACA Chips At Core Goal Of Reducing Uninsured

April 21, 2014 2:39 pm | by Judy Lin, Associated Press | News | Comments

Questions of affordability, eligibility, immigrant access and the response from employers and...

Court Won't Block Ruling In Patent Case

April 21, 2014 10:30 am | by Sam Hananel, Associated Press | News | Comments

Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court...

View Sample

FREE Email Newsletter

Daily news and top headlines for manufacturing professionals

Automating Purchasing, Production & Customer Service on Three Continent

April 21, 2014 9:57 am | Videos | Comments

IDT uses Microsoft Dynamics AX ERP software, implemented by Edgewater Fullscope, to support new products and market expansion, as well as address traceability requirements. IDT processes over 25,000 products per day and has over 86,000 customers around the world.

Judge Blocks Mass. Ban On Zohydro

April 16, 2014 7:56 am | by Steve LeBlanc, Associated Press | News | Comments

The judge issued a preliminary injunction Tuesday after pharmaceutical company, Zogenix, argued in a lawsuit that the ban issued by Gov. Deval Patrick in March is unconstitutional.                

Prescription Drug Spending Climbs In 2013

April 15, 2014 3:04 pm | News | Comments

Total U.S. prescription drug spending climbed more than 3 percent last year, propelled in part by fewer patent expirations that would have allowed for cheaper generic alternatives, according to the data firm IMS Health.       

Advertisement

Herbalife Denies Criminal Probe Report

April 14, 2014 1:00 pm | News | Comments

The company said in a statement that it has no knowledge of any ongoing investigation by the DOJ or the FBI. It also said that it has not received any request for information from either agency.           

Report Says Glaxo Bribed Doctors In Poland

April 14, 2014 11:01 am | News | Comments

The British drug company faces corruption probes in China and Iraq. It said in a statement it is cooperating with investigators and that one employee had been disciplined in 2011 for inappropriate actions.              

Ban On Painkiller Raises Constitutional Questions

April 9, 2014 8:32 am | by Philip Marcelo, Associated Press | News | Comments

Gov. Deval Patrick defended the state's first-in-the-nation ban of the powerful new painkiller Zohydro after a federal judge suggested in court that his administration may have overreached.                 

Teva Launches Generic Fish Oil Drug

April 8, 2014 3:31 pm | News | Comments

Teva Pharmaceutical Industries said Tuesday it is now selling a generic version of the heart medication Lovaza, which is used to treat high triglyceride levels.                

Mallinckrodt To Buy Questcor For About $5.6B

April 8, 2014 9:01 am | News | Comments

Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business.          

Advertisement

Zohydro Maker Sues To Block Ban

April 8, 2014 8:15 am | News | Comments

The maker of Zohydro, a controversial new prescription painkiller, has filed a lawsuit in federal court seeking to block Massachusetts' ban on local doctors prescribing and dispensing the drug.           

Takeda, Eli Lilly Hit With $9B Penalty

April 8, 2014 7:43 am | by Yuri Kageyama, AP Business Writer | News | Comments

A U.S. jury ordered Takeda Pharmaceutical Co. and Eli Lilly to pay $9 billion in punitive damages over a diabetes medicine linked to cancer.                   

GSK Probes Iraq Bribery Claims

April 7, 2014 12:57 pm | by Sylvia Hui, Associated Press | News | Comments

GlaxoSmithKline said Monday it has launched an investigation into allegations it bribed doctors in Iraq, as the pharmaceuticals giant remains embroiled in a major corruption scandal in China.            

Sun Pharma Buys Ranbaxy In $4B Deal

April 7, 2014 7:50 am | by Kay Johnson, AP Business Writer | News | Comments

India's Sun Pharmaceutical Industries is buying troubled generic drug maker Ranbaxy Laboratories in a $4 billion deal, the companies said Monday.                   

States Revolt Against New Painkiller

April 4, 2014 10:38 am | by Beth Garbitelli, Associated Press | News | Comments

The backlash against Zohydro has been growing since last year, when the FDA approved the drug against the recommendation of an internal advisory committee.                  

Advertisement

Little Evidence Of Threats To Execution Drug Makers

April 4, 2014 8:05 am | by Bailey Elise McBride and Nomaan Merchant, Associated Press | News | Comments

Texas prison officials have offered scant evidence to support their claim that pharmacies that supply the state with execution drugs would be in danger of violence if their identities were made public.          

Actavis Plans To Spend $100M On Generic Drug Maker

April 1, 2014 3:21 pm | News | Comments

Drug maker Actavis Plc plans to expand its reach into Southeast Asia by spending about $100 million to buy Silom Medical Co., a generic pharmaceutical company focused on Thailand.              

GlaxoSmithKline Recalls Drug After Foreign Pills Found In Bottles

March 27, 2014 12:31 pm | News | Comments

GlaxoSmithKline is recalling the weight loss drug Alli after receiving reports of unknown pills and tablets in the bottles.                       

Zohydro Maker Touts Drug Safety Board

March 27, 2014 10:08 am | by Matthew Perrone, AP Health Writer | News | Comments

After months of criticism over its recently launched painkiller Zohydro, the maker of the powerful narcotic is highlighting an unusual oversight board that it's assembled to try and prevent abuse of the drug.        

25 Companies To Phase Out Animal Antibiotics

March 27, 2014 8:51 am | by Mary Clare Jalonick, Associated Press | News | Comments

Twenty-five pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat, the Food and Drug Administration said Wednesday.            

Court Tosses $1.2B Judgment Against J&J

March 20, 2014 11:29 am | by Chuck Bartels, Associated Press | News | Comments

The Arkansas Supreme Court on Thursday overturned a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging the drug maker's marketing of the antipsychotic drug Risperdal.           

Hawaii AG Sues Makers Of Plavix

March 20, 2014 8:32 am | News | Comments

Hawaii's attorney general is suing the makers of a widely prescribed blood thinner that he says a significant portion of the state's population has difficulty metabolizing.               

Horizon Pharma Buying Vidara For About $660M

March 19, 2014 9:52 am | News | Comments

Horizon Pharma plans to buy Vidara Therapeutics International in a cash-and-stock deal that will add the immune system disorder drug Actimmune to the specialty drug maker's product portfolio.           

Study To Test 'Chocolate' Pills For Heart Health

March 18, 2014 7:57 am | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

The pills are so packed with nutrients that you'd have to eat a gazillion candy bars to get the amount being tested in this study, which will enroll 18,000 men and women nationwide.              

FDA Defends Hydrocodone Drug Approval

March 13, 2014 12:40 pm | News | Comments

The head of the Food and Drug Administration says the much-debated painkiller Zohydro fills an "important and unique niche" for treating pain.                     

Maker Of OxyContin Will Offer Abuse-Resistant Zohydro

March 12, 2014 12:30 pm | News | Comments

Purdue Pharma says it has completed testing of an abuse-resistant version of the painkiller hydrocodone, a surprise development that could derail sales of the recently launched Zohydro.            

Medical Groups Question $1,000 Price Tag Of New Hep C Drug

March 11, 2014 12:18 pm | by Matthew Perrone, AP Health Writer | News | Comments

A drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care experts, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences.        

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading